Search research articles
Contact Us
Filters
Showing results (1-10 of 20) with videos related to
Page
of 2
Sort By:
Asian Pacific Journal of Cancer Prevention : APJCP
|
October 31, 2015
Impact of Omega-3 Fatty Acid Supplements on Gastrointestinal Cancer Patients after Surgery: Beneficial or Useless?
Haibin Zhang, Jing Zhang, Haiyong Wang, et al.
Frontiers in Oncology
|
July 7, 2022
Complete Response to Immunotherapy Combined With Chemotherapy in a Patient With Gynecological Mixed Cancer Mainly Composed of Small Cell Neuroendocrine Carcinoma With High Tumor Mutational Burden: A Case Report
Xingyun Su, Xinhui Zhou, Cheng Xiao, et al.
Oncotargets and Therapy
|
September 12, 2014
ER-α36: a novel biomarker and potential therapeutic target in breast cancer
Xingyun Su, Xin Xu, Guangliang Li, et al.
Oncotargets and Therapy
|
May 14, 2016
Diagnostic value of BRAF (V600E)-mutation analysis in fine-needle aspiration of thyroid nodules: a meta-analysis
Xingyun Su, Xiaoxia Jiang, Xin Xu, et al.
American Journal of Translational Research
|
May 18, 2016
Galectin-1 mediates TGF-β-induced transformation from normal fibroblasts into carcinoma-associated fibroblasts and promotes tumor progression in gastric cancer
Lingyan Zheng, Cong Xu, Zhonghai Guan, et al.
Biomed Research International
|
November 13, 2018
GPRC5A: An Emerging Biomarker in Human Cancer
Xiaoxia Jiang, Xin Xu, Mengjie Wu, et al.
International Journal of Endocrinology
|
October 5, 2019
Nomogram-Based New Recurrence Predicting System in Early-Stage Papillary Thyroid Cancer
Yongfeng Ding, Zhuochao Mao, Jiaying Ruan, et al.
Immunopharmacology and Immunotoxicology
|
January 17, 2025
Artificial liver support systems bridge severe immune-mediated hepatotoxicity to clinical recovery
Qiangfeng Wang, Cheng Xiao, Peipei Hu, et al.
Oncotargets and Therapy
|
December 14, 2016
Association of telomerase reverse transcriptase promoter mutations with clinicopathological features and prognosis of thyroid cancer: a meta-analysis
Xingyun Su, Xiaoxia Jiang, Weibin Wang, et al.
International Journal of Endocrinology
|
April 30, 2026
BRAF Mutation Status Determines the Prognostic Value of Tumor Bilaterality in Papillary Thyroid Carcinoma: A Retrospective Cohort Study
Shitu Chen, Fang Chen, Xingyun Su, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 20) with videos related to
Sort By:
Page
of 2
Asian Pacific Journal of Cancer Prevention : APJCP
|
October 31, 2015
Impact of Omega-3 Fatty Acid Supplements on Gastrointestinal Cancer Patients after Surgery: Beneficial or Useless?
Haibin Zhang, Jing Zhang, Haiyong Wang, et al.
Frontiers in Oncology
|
July 7, 2022
Complete Response to Immunotherapy Combined With Chemotherapy in a Patient With Gynecological Mixed Cancer Mainly Composed of Small Cell Neuroendocrine Carcinoma With High Tumor Mutational Burden: A Case Report
Xingyun Su, Xinhui Zhou, Cheng Xiao, et al.
Oncotargets and Therapy
|
September 12, 2014
ER-α36: a novel biomarker and potential therapeutic target in breast cancer
Xingyun Su, Xin Xu, Guangliang Li, et al.
Oncotargets and Therapy
|
May 14, 2016
Diagnostic value of BRAF (V600E)-mutation analysis in fine-needle aspiration of thyroid nodules: a meta-analysis
Xingyun Su, Xiaoxia Jiang, Xin Xu, et al.
American Journal of Translational Research
|
May 18, 2016
Galectin-1 mediates TGF-β-induced transformation from normal fibroblasts into carcinoma-associated fibroblasts and promotes tumor progression in gastric cancer
Lingyan Zheng, Cong Xu, Zhonghai Guan, et al.
Biomed Research International
|
November 13, 2018
GPRC5A: An Emerging Biomarker in Human Cancer
Xiaoxia Jiang, Xin Xu, Mengjie Wu, et al.
International Journal of Endocrinology
|
October 5, 2019
Nomogram-Based New Recurrence Predicting System in Early-Stage Papillary Thyroid Cancer
Yongfeng Ding, Zhuochao Mao, Jiaying Ruan, et al.
Immunopharmacology and Immunotoxicology
|
January 17, 2025
Artificial liver support systems bridge severe immune-mediated hepatotoxicity to clinical recovery
Qiangfeng Wang, Cheng Xiao, Peipei Hu, et al.
Oncotargets and Therapy
|
December 14, 2016
Association of telomerase reverse transcriptase promoter mutations with clinicopathological features and prognosis of thyroid cancer: a meta-analysis
Xingyun Su, Xiaoxia Jiang, Weibin Wang, et al.
International Journal of Endocrinology
|
April 30, 2026
BRAF Mutation Status Determines the Prognostic Value of Tumor Bilaterality in Papillary Thyroid Carcinoma: A Retrospective Cohort Study
Shitu Chen, Fang Chen, Xingyun Su, et al.
Page
of 2